Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

Author： Cinzia Nigro Michela Donadio Mara Ardine Alessandra Beano Marinella Mistrangelo Zaira Coccorullo Oscar Bertetto

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.3, Iss.4, 2004-01, pp. : 257-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

By Ripamonti Carla

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1177-1184

Springer Publishing Company

Access to resources Recommend Favorite

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

By Zhao Xinmin

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 733-743

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 226-230

Spandidos Publications

Access to resources Recommend Favorite

Relevance of Micrometastases and Targeting the Bone Marrow Niche with Zoledronic Acid in Breast Cancer

Current Cancer Therapy Reviews, Vol. 8, Iss. 2, 2012-05 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite

Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients

By Sciuto R. Festa A. Pasqualoni R. Semprebene A. Rea S. Bergomi S. Maini C.L.

Breast Cancer Research and Treatment, Vol. 66, Iss. 2, 2001-03 ,pp. : 101-109

Springer Publishing Company

Access to resources Recommend Favorite